about
MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study.Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study.Multidisciplinary approach of colorectal cancer liver metastases.Regional chemotherapy for carcinoma of the lung.Surgical versus percutaneous isolated pelvic perfusion (IPP) for advanced melanoma: comparison in terms of melphalan pharmacokinetic pelvic bio-availability.Mitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques.Short- and Long-Term, 11-22 Years, Results after Laparoscopic Nissen Fundoplication in Obese versus Nonobese Patients.Chemoembolization Adopting Polyethylene Glycol Drug-Eluting Embolics Loaded With Doxorubicin for the Treatment of Hepatocellular Carcinoma.A single thyroid nodule revealing early metastases from clear cell renal carcinoma: case report and review of literature.Arterial vasculature of the stomach and oncologic gastrectomies.Loco-regional perfusions (stop-flow techniques): state of art and future.Prognostic factors in patients with advanced pancreatic adenocarcinoma treated with intra-arterial chemotherapy.Regional plus systemic chemotherapy: an effective treatment in recurrent non-small cell lung cancer.Chronic atrophic gastritis and risk of N-nitroso compounds carcinogenesis.Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma.Intraluminal ileal tumour after right hemicolectomy for cancer: An implantation recurrence or a new cancer? A case report.Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?Resolution of type 2 diabetes after sleeve gastrectomy: a 2-step hypothesis.Melphalan hypoxic perfusion with hemofiltration for melanoma locoregional metastases in the pelvis.N-Nitroso compounds, bacteria, and carcinoembryonic antigen in the gastric stump.The microflora of the gastric juice after Billroth I and Billroth II partial gastrectomy.Hypoxic abdominal stop-flow perfusion in the treatment of advanced pancreatic cancer: a phase II evaluation/trial.Chronic lymphocytic leukaemia and neuroendocrine cancer.High Resected Gastric Volume and poorly controlled DM2 in laparoscopic sleeve gastrectomyHypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanomaLow anterior resection versus abdominoperineal excision: a comparison of local recurrence after curative surgery for "very low" rectal cancerSurgical treatment of retrograde jejunogastric intussusception after temporary endoscopic management[Digestive hemorrhage caused by rupture of an aneurysm of the superior pancreaticoduodenal artery]Ulcerated ectopic gastric mucosa of the rectumEvaluation of carcinoembryonic antigen levels in gastric juice, stomach mucosa and plasma in high-risk and gastric cancer patientsN-nitroso compounds in the gastric juice of normal controls, patients with partial gastrectomies, and gastric cancer patientsCombination of granulocyte-macrophage colony-stimulating factor (GM-CSF) anf erythropoietin (EPO) for the treatment of advanced non-responsive chronic lymphocytic leukemiaEvaluation of the Maruyama computer program accuracy for preoperative estimation of lymph node metastases from gastric cancerMultiple gastric lipomas: report of an asymptomatic case found at autopsySignificance of duplex/colour Doppler sonography in hepatic arterial chemotherapy for patients with liver metastases from colorectal carcinomaIntra-arterial chemotherapy for unresectable pancreatic cancerIsolated hypoxic perfusion with mitomycin C in patients with advanced pancreatic cancer[Isolation regional perfusion]Thoracic stop-flow perfusion for refractory lymphoma: a phase I-II evaluation trialSuccessful laparoscopic trans-peritoneal repair of an incisional inguinal hernia, resulting from deep lymph node dissection for melanoma: A case report
P50
Q30491635-55F8EFEB-342A-44FF-A051-FF6C51107AFAQ30835097-4CED42C3-3714-4342-9EA0-33B2C928C3A6Q33779859-9B13690E-18BB-40ED-AEBB-F0C513503554Q37250523-066DEF6D-74C0-42E6-95E5-F2374FC32BD6Q38372151-6EA0C094-2423-49A5-BF38-FBC97C73E877Q38372485-5B3EC1C6-163C-4B01-A216-5B8C6EC3DB99Q38741820-95D8F760-5D86-41CC-A7CA-30ABDAACA8E1Q38767491-EBF1CA7E-D4EC-4A21-8F4E-A150072443FCQ39219737-2640934D-0493-48C4-B323-89F17FCA53C9Q39369724-71F72E45-2E0B-4E00-AD2E-0C3BBD719271Q40317207-D8ED229D-A2B0-4EE9-993E-54882F97336FQ43487840-294C65DE-06E7-46AF-958C-DCC9FFC00D77Q43566714-0D74D41D-DAAA-4018-9C80-E09E5A0CAB95Q43789402-50EE0879-9FC8-4EB9-8083-570FD0CB194AQ43899253-9D925D3D-7E25-4E12-884B-D1AA87E1D725Q44388530-5D79FDB7-B56E-4F15-9C48-26D714148131Q47163375-7917ADFC-6C7B-4BBD-BC86-AEA79FB0776CQ50022028-229FC18C-D646-4C0E-BD68-C669EB52EE80Q50540693-A9F655E2-7B4A-4DC7-8630-B74F3195369EQ51565824-EB23E814-30C0-4C82-B8ED-749AF3173247Q51633881-A6057035-08D7-446B-957A-B22252287844Q53508654-66A7A730-CBD7-44C7-AAB8-D028C6BDDA59Q54072973-3847749C-5870-4E27-B91B-B6B66169DE06Q59336929-CE1F52C1-72FF-4DF7-8F8A-68151E747B2DQ62711409-F7468305-D357-4490-90BD-7DFED76C9F81Q67551209-794E2D12-CCF9-4983-A55B-DC1C485FADB4Q68006554-AC2881F0-EA3C-4DA1-AEC0-DFE207D2FD77Q68073840-5F458A3D-39AC-47C0-9EC3-6F0212027B50Q68816984-5C3CB617-A088-4D85-9E60-4D660054BBFAQ69498744-815D2CA9-C117-4364-9FA3-8C72D62B0950Q71942299-6E21FACF-AD44-4008-B62C-BD0395CF6F75Q73225001-F257EA2D-728F-4DE0-B7CC-94966D0DC08EQ73476143-F820632F-73AC-4D29-B300-32509552349DQ73688649-1EC052C5-4AE9-4C54-AF48-13D2FD72FC2CQ73938068-91282E95-0265-4071-ABCE-35D8D700E9FEQ74044389-7FFB868B-0756-4B26-A90F-937A03C58209Q77773910-30725639-BE38-464B-B17D-316FE8E2105FQ78472587-A18BA756-9F14-4EB2-A798-25E1D0E76E25Q83861882-F0ECE769-4FD4-4E71-A141-607683578275Q89651903-3A5409EB-2DC3-4D0B-8FDE-C19628C6A244
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stefano Guadagni
@ast
Stefano Guadagni
@en
Stefano Guadagni
@es
Stefano Guadagni
@nl
Stefano Guadagni
@sl
type
label
Stefano Guadagni
@ast
Stefano Guadagni
@en
Stefano Guadagni
@es
Stefano Guadagni
@nl
Stefano Guadagni
@sl
prefLabel
Stefano Guadagni
@ast
Stefano Guadagni
@en
Stefano Guadagni
@es
Stefano Guadagni
@nl
Stefano Guadagni
@sl
P106
P21
P31
P496
0000-0001-8525-084X